This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignee: Glykos Finland Oy. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Georg Schmidt - Innovator in Glycoprotein Production
Introduction
Georg Schmidt is a notable inventor based in Nahkela, Finland. He has made significant contributions to the field of biotechnology, particularly in the production of glycoproteins. His innovative work focuses on utilizing filamentous fungi for the production of recombinant glycoproteins with mammalian-like N-glycans.
Latest Patents
Georg Schmidt holds a patent for the "Production of glycoproteins with mammalian-like N-glycans in filamentous fungi." This patent describes compositions and methods that are useful for producing recombinant glycoproteins in filamentous fungal cells. The invention ensures that at least 90% of the total neutral N-glycans of the produced recombinant glycoprotein are mammalian-like N-glycans. The patented technology involves specific mutations in fungal cells that reduce or eliminate endogenous protease activity, along with the introduction of polynucleotides that enhance glycoprotein production.
Career Highlights
Throughout his career, Georg Schmidt has worked with several companies, including Glykos Finland Oy and Biomay AG. His expertise in biotechnology and glycoprotein production has made him a valuable asset in these organizations. His work has contributed to advancements in the field, particularly in the development of more efficient methods for glycoprotein production.
Collaborations
Georg Schmidt has collaborated with notable professionals in his field, including Jari Natunen and Anne Leppänen. These collaborations have further enhanced his research and development efforts in glycoprotein technology.
Conclusion
Georg Schmidt's innovative work in the production of glycoproteins has positioned him as a key figure in biotechnology. His contributions continue to influence the industry and pave the way for future advancements in recombinant protein production.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile